Vaccine against dengue being developed: Govt

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 6:29 AM IST

Health Minister Ghulam Nabi Azad told the Lok Sabha that the trials of the vaccine are at an advanced stage in several countries, including in India, and hoped these would pass.

"The phase III of the trial is underway in the Philippines, Vietnam, Malaysia, Indonesia and Latin American countries....In India the trials are taking place in places like Ludhiana, Kolkata and Delhi. If it passes, the day is not far when we will get it," he said.

Azad was responding to a call attention on the spread of dengue and the steps taken by the government in this regard, with members asking the government to take foreign help or even FDI to meet the "serious" situation.

He hoped that the success of these trials by the French company, Sanofi Pasteur, come sooner than later so that deaths taking place due to dengue can be contained.

The Minister said the spread of dengue infection has "shown an increase in recent years due to various man-made and environmental factors leading to proliferation of Aedes mosquito breeding sites, both in urban and rural areas."

Observing that the dimension of the problem could be gauged by the number of cases reported and deaths, he said up to November 15 this year, 35,066 cases, including 216 deaths, have been reported. However, the case fatality rate has remained low at 0.6 per cent.

The total number of suspected Chikungunya cases has declined, with 14,227 reported till November 15.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 30 2012 | 2:35 PM IST

Next Story